Dr. Robin L. Smith is a global thought leader in regenerative medicine. She received her M.D. from the Yale School of Medicine and MBA from the Wharton School of Business. During her tenure as CEO of the NeoStem family of companies (NASDAQ: NBS now CLBS) from 2006 to 2015, she pioneered the company’s innovative business model, combining proprietary cell therapy development with a successful contract development and manufacturing organization. Dr. Smith raised over $240 million, completing six acquisitions and one divestiture while the company won an array of industry awards including a first-place ranking in the tri-state area (two years in a row), and eleventh place nationally, on Deloitte’s Technology Fast 500 and Frost & Sullivan’s North American Cell Therapeutics Technology Innovation Leadership Award.

In 2007, Dr. Smith founded the Stem for Life Foundation (SFLF), devoted to fostering global awareness of the potential for regenerative medicine to treat and cure a range of deadly diseases and debilitating medical conditions. In 2010, Dr. Smith forged a historic, first-of-its-kind partnership with the Vatican, bringing the charity’s mission to a global audience. As part of this relationship, the Vatican and SFLF create high-profile initiatives to catalyze interest and investment to reduce human suffering on a global scale. Dr. Smith has served as chairman of the board and president of SFLF since its inception and has been expanding its mission further under the Cura brand since 2016.

Dr. Smith was appointed as clinical associate professor, department of medicine at the Rutgers New Jersey Medical School in 2017. Dr. Smith maintained a regular column for the Huffington Post for six years and co-authored “Cells Are the New Cure” and “The Healing Cell: How the Greatest Revolution in Medical History Is Changing Your Life.” She was elected to the 2018 NACD Directorship 100: Directors list by the NACD Directorship magazine for her work and expertise in corporate governance. Dr. Smith is a winner of the 2014 Brava! Award, which recognizes top women business leaders in the New York area. She was a finalist for the 2014 EY Entrepreneur of the Year Award for the New York area. In April 2016, Pope Francis awarded Dr. Smith Dame Commander with Star Pontifical Equestrian Order of Saint Sylvester Pope and Martyr. Dr. Smith was awarded the Lifetime Achievement in Healthcare and Science Award by The National Museum of Catholic Art and Library in May 2017.

Dr. Smith has extensive experience serving in executive- and board-level capacities for various health care-based enterprises. She is currently chairman of the board of directors of MYnd Analytics (NASDAQ: MYND, formerly CNS Response), serves on the board of directors of Rockwell Medical (NASDAQ: RMTI). Additionally, she served on the board of Signal Genetics (NASDAQ:SGNL) and Prolung DX chairing the nominating and governance committee. She is co-chairman of the Life Sci advisory board on gender diversity. She is the founder and president of the Cura Foundation, Stem for Life Foundation, and Cognitive Warriors and vice president and member of the board of directors of the Science and Faith – STOQ Foundation in Rome and serves on Sanford Health’s International Board and the board of overseers at the NYU Langone Medical Center in NYC after serving on the board of trustees for five years and chairman of the board of the New York Hospital for Joint Diseases for five years.

As a business leader, entrepreneur, doctor and philanthropist, Dr. Smith is uniquely positioned to lead the global health care industry into the cellular future—a future where the cells of our bodies will stand as the foundation for a wide array of cures and big data will assist physicians to determine the best course of treatment for individual patients.

Dr. Max Gomez is one of TV’s most respected medical journalists. He has produced award-winning health and science segments for network stations in New York and Philadelphia.  Dr. Max has reported for Dateline, the Today Show, and 48 Hours. Over more than three decades, he’s earned nine Emmy Awards, three NY State Broadcaster’s Association Awards, and UPI’s Best Documentary Award.

In addition to New York City’s Excellence in Time of Crisis for his September 11 coverage, Dr. Max has been singled out nationally for special award recognition by the Leukemia and Lymphoma Society and the National Marfan Foundation.  He was also named the American Health Foundation’s Man of the Year.

A noted moderator and speaker, Dr. Max has been the regular moderator for Memorial Sloan Kettering’s Cancer Smart public education series. He was also an organizer and moderator for two international conferences on adult stem cells hosted by and held at the Vatican. Dr. Max also trains physicians nationally in public speaking and presentation, speaking to groups as diverse as the National Cancer Institute and the College of American Pathologists.

Dr. Max is the coauthor of The Healing Cell: How the Greatest Revolution in Medical History Is Changing Your Life, a layman’s guide to the medicine of the future, showcasing a wide array of emerging adult stem cell breakthroughs, including their ability to repair damaged hearts and organs, restore sight, kill cancer, cure diabetes, heal burns, and stop the march of degenerative diseases, such as Alzheimer’s, multiple sclerosis, and Lou Gehrig’s disease. Covering stem cell applications in everything from orthopedics to heart disease, cancer, and HIV, it includes a special address by Pope Benedict XVI urging increased support and awareness for advancements in adult stem cell research in order to alleviate human suffering.

Dr. Max is also the coauthor of The Prostate Health Program: A Guide to Preventing and Controlling Prostate Cancer.  The 384-page book explains how an innovative program consisting of diet, exercise, and lifestyle changes may help prevent prostate cancer.

Among the boards he serves or has served on are: The Stem for Life Foundation; American Heart Association, national and regional boards; past chair of the national communications committee for the American Heart Association; past vice chair of Princeton Alumni Weekly’s board; Science Writers Fellowship at the Marine Biological Laboratory in Woods Hole, MA; Crohn’s and Colitis Foundation of America—Long Island Chapter; The Partnership for After School Education, a citywide group of 1,600 community-based programs that tutor and mentor students; past chair of the communications committee for the American Association for the Advancement of Science; Cognitive Warriors, a Cura Foundation.

Dr. Max also mentors undergraduate journalism students, as well as medical students and physicians who are interested in medical journalism.  He is an honors graduate of Princeton University and the Wake Forest University School of Medicine (PhD in Neuroscience) and was an NIH postdoctoral fellow at Rockefeller University.

Mr. Martin is the Managing Member and a founder of Aspire Capital Fund, LLC a Chicago-based investment fund started in 2010 which has invested over $250 million in small emerging growth companies. Aspire Capital is focused on investing in life science companies and promoting early stage clinical development of cellular therapies and regenerative medicine. Mr. Martin has thirty years of legal and financing experience and has funded or committed to fund over $1.5 billion in investments. During his career, Mr. Martin has invested in hundreds of development-stage companies and many emerging cell therapy companies catalyzing their growth.

​

In 1999, Mr. Martin also founded Fusion Capital, a private investment fund which over ten years funded small emerging growth companies with a focus on life science companies. Prior to Fusion Capital, Mr. Martin was a partner at the Chicago law firm of Katten Muchin Rosenman LLP. As an attorney, Mr. Martin represented institutional investors and companies in highly complex financings as well as venture capital and private equity transactions.

​

Mr. Martin received his Juris Doctor degree with honors from Northwestern University School of Law. Mr. Martin graduated with high honors from the University of Michigan with a Bachelors of Business Administration, concentrating in finance.